Selected research
Market Outlook & Growth Opportunities
Global Crisaborole Market Outlook and Growth Opportunities 2026
Market perspective
The global Crisaborole market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Crisaborole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Crisaborole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Crisaborole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Crisaborole market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Crisaborole market include Neuraxpharm, Tapi Teva, VIRUJ PHARMA, Synergy Pharmaceutical and Ausun Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Crisaborole market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Crisaborole and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Crisaborole sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Crisaborole market size, projected growth trends, production technologies, key applications, and end-use industries.
Crisaborole Segment by Company
Neuraxpharm
Tapi Teva
VIRUJ PHARMA
Synergy Pharmaceutical
Ausun Pharmaceutical
Crisaborole Segment by Type
Purity Above 98%
Purity Below 98%
Crisaborole Segment by Application
Allergic Dermatitis
Other
Crisaborole Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Crisaborole status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Crisaborole market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Crisaborole significant trends, drivers, influence factors in global and regions.
6. To analyze Crisaborole competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crisaborole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Crisaborole and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crisaborole.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Crisaborole market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Crisaborole industry.
Chapter 3: Detailed analysis of Crisaborole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Crisaborole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Crisaborole in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity Above 98%
- Purity Below 98%
Applications
- Allergic Dermatitis
- Other
Companies covered
- Neuraxpharm
- Tapi Teva
- VIRUJ PHARMA
- Synergy Pharmaceutical
- Ausun Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Crisaborole Sales Value (2021-2032)
- 1.2.2 Global Crisaborole Sales Volume (2021-2032)
- 1.2.3 Global Crisaborole Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Crisaborole Market Dynamics
- 2.1 Crisaborole Industry Trends
- 2.2 Crisaborole Industry Drivers
- 2.3 Crisaborole Industry Opportunities and Challenges
- 2.4 Crisaborole Industry Restraints
3 Crisaborole Market by Company
- 3.1 Global Crisaborole Company Revenue Ranking in 2025
- 3.2 Global Crisaborole Revenue by Company (2021-2026)
- 3.3 Global Crisaborole Sales Volume by Company (2021-2026)
- 3.4 Global Crisaborole Average Price by Company (2021-2026)
- 3.5 Global Crisaborole Company Ranking (2024-2026)
- 3.6 Global Crisaborole Company Manufacturing Base and Headquarters
- 3.7 Global Crisaborole Company Product Type and Application
- 3.8 Global Crisaborole Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Crisaborole Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Crisaborole Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Crisaborole Market by Type
- 4.1 Crisaborole Type Introduction
- 4.1.1 Purity Above 98%
- 4.1.2 Purity Below 98%
- 4.2 Global Crisaborole Sales Volume by Type
- 4.2.1 Global Crisaborole Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Crisaborole Sales Volume by Type (2021-2032)
- 4.2.3 Global Crisaborole Sales Volume Share by Type (2021-2032)
- 4.3 Global Crisaborole Sales Value by Type
- 4.3.1 Global Crisaborole Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Crisaborole Sales Value by Type (2021-2032)
- 4.3.3 Global Crisaborole Sales Value Share by Type (2021-2032)
5 Crisaborole Market by Application
- 5.1 Crisaborole Application Introduction
- 5.1.1 Allergic Dermatitis
- 5.1.2 Other
- 5.2 Global Crisaborole Sales Volume by Application
- 5.2.1 Global Crisaborole Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Crisaborole Sales Volume by Application (2021-2032)
- 5.2.3 Global Crisaborole Sales Volume Share by Application (2021-2032)
- 5.3 Global Crisaborole Sales Value by Application
- 5.3.1 Global Crisaborole Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Crisaborole Sales Value by Application (2021-2032)
- 5.3.3 Global Crisaborole Sales Value Share by Application (2021-2032)
6 Crisaborole Regional Sales and Value Analysis
- 6.1 Global Crisaborole Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Crisaborole Sales by Region (2021-2032)
- 6.2.1 Global Crisaborole Sales by Region: 2021-2026
- 6.2.2 Global Crisaborole Sales by Region (2027-2032)
- 6.3 Global Crisaborole Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Crisaborole Sales Value by Region (2021-2032)
- 6.4.1 Global Crisaborole Sales Value by Region: 2021-2026
- 6.4.2 Global Crisaborole Sales Value by Region (2027-2032)
- 6.5 Global Crisaborole Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Crisaborole Sales Value (2021-2032)
- 6.6.2 North America Crisaborole Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Crisaborole Sales Value (2021-2032)
- 6.7.2 Europe Crisaborole Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Crisaborole Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Crisaborole Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Crisaborole Sales Value (2021-2032)
- 6.9.2 South America Crisaborole Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Crisaborole Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Crisaborole Sales Value Share by Country, 2025 VS 2032
7 Crisaborole Country-level Sales and Value Analysis
- 7.1 Global Crisaborole Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Crisaborole Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Crisaborole Sales by Country (2021-2032)
- 7.3.1 Global Crisaborole Sales by Country (2021-2026)
- 7.3.2 Global Crisaborole Sales by Country (2027-2032)
- 7.4 Global Crisaborole Sales Value by Country (2021-2032)
- 7.4.1 Global Crisaborole Sales Value by Country (2021-2026)
- 7.4.2 Global Crisaborole Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Crisaborole Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Crisaborole Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Crisaborole Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Crisaborole Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Crisaborole Sales Value Growth Rate (2021-2032)
- 7.9.2 France Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Crisaborole Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Crisaborole Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Crisaborole Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Crisaborole Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Crisaborole Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Crisaborole Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Crisaborole Sales Value Growth Rate (2021-2032)
- 7.16.2 China Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Crisaborole Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Crisaborole Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Crisaborole Sales Value Growth Rate (2021-2032)
- 7.19.2 India Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Crisaborole Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Crisaborole Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Crisaborole Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Crisaborole Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Crisaborole Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Crisaborole Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Crisaborole Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Crisaborole Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Crisaborole Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Crisaborole Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Crisaborole Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Crisaborole Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Crisaborole Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Crisaborole Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Crisaborole Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Crisaborole Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Neuraxpharm
- 8.1.1 Neuraxpharm Company Information
- 8.1.2 Neuraxpharm Business Overview
- 8.1.3 Neuraxpharm Crisaborole Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Neuraxpharm Crisaborole Product Portfolio
- 8.1.5 Neuraxpharm Recent Developments
- 8.2 Tapi Teva
- 8.2.1 Tapi Teva Company Information
- 8.2.2 Tapi Teva Business Overview
- 8.2.3 Tapi Teva Crisaborole Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Tapi Teva Crisaborole Product Portfolio
- 8.2.5 Tapi Teva Recent Developments
- 8.3 VIRUJ PHARMA
- 8.3.1 VIRUJ PHARMA Company Information
- 8.3.2 VIRUJ PHARMA Business Overview
- 8.3.3 VIRUJ PHARMA Crisaborole Sales, Value and Gross Margin (2021-2026)
- 8.3.4 VIRUJ PHARMA Crisaborole Product Portfolio
- 8.3.5 VIRUJ PHARMA Recent Developments
- 8.4 Synergy Pharmaceutical
- 8.4.1 Synergy Pharmaceutical Company Information
- 8.4.2 Synergy Pharmaceutical Business Overview
- 8.4.3 Synergy Pharmaceutical Crisaborole Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Synergy Pharmaceutical Crisaborole Product Portfolio
- 8.4.5 Synergy Pharmaceutical Recent Developments
- 8.5 Ausun Pharmaceutical
- 8.5.1 Ausun Pharmaceutical Company Information
- 8.5.2 Ausun Pharmaceutical Business Overview
- 8.5.3 Ausun Pharmaceutical Crisaborole Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Ausun Pharmaceutical Crisaborole Product Portfolio
- 8.5.5 Ausun Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Crisaborole Value Chain Analysis
- 9.1.1 Crisaborole Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Crisaborole Sales Mode & Process
- 9.2 Crisaborole Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Crisaborole Distributors
- 9.2.3 Crisaborole Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst